Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AUVI logo

Applied UV Inc (AUVI)AUVI

Upturn stock ratingUpturn stock rating
Applied UV Inc
$0.01
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

07/30/2024: AUVI (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -65.2%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 49
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 07/30/2024
Type: Stock
Today’s Advisory: PASS
Profit: -65.2%
Avg. Invested days: 49
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/30/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.37M USD
Price to earnings Ratio -
1Y Target Price 40
Dividends yield (FY) -
Basic EPS (TTM) -40
Volume (30-day avg) 42480
Beta -1.1
52 Weeks Range 0.01 - 13.32
Updated Date 08/25/2024
Company Size Small-Cap Stock
Market Capitalization 1.37M USD
Price to earnings Ratio -
1Y Target Price 40
Dividends yield (FY) -
Basic EPS (TTM) -40
Volume (30-day avg) 42480
Beta -1.1
52 Weeks Range 0.01 - 13.32
Updated Date 08/25/2024

Earnings Date

Report Date 2024-08-12
When BeforeMarket
Estimate -
Actual -
Report Date 2024-08-12
When BeforeMarket
Estimate -
Actual -

Profitability

Profit Margin -32.43%
Operating Margin (TTM) -56.88%

Management Effectiveness

Return on Assets (TTM) -17.97%
Return on Equity (TTM) -62.7%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 11684081
Price to Sales(TTM) 0.07
Enterprise Value to Revenue 0.52
Enterprise Value to EBITDA -1.39
Shares Outstanding 4674500
Shares Floating 4034150
Percent Insiders 1.52
Percent Institutions 6.19
Trailing PE -
Forward PE -
Enterprise Value 11684081
Price to Sales(TTM) 0.07
Enterprise Value to Revenue 0.52
Enterprise Value to EBITDA -1.39
Shares Outstanding 4674500
Shares Floating 4034150
Percent Insiders 1.52
Percent Institutions 6.19

Analyst Ratings

Rating 5
Target Price 5.25
Buy -
Strong Buy 1
Hold -
Sell -
Strong Sell -
Rating 5
Target Price 5.25
Buy -
Strong Buy 1
Hold -
Sell -
Strong Sell -

AI Summarization

Applied UV Inc. (AUVI) Overview

Company Profile:

Detailed history and background: Applied UV Inc. (AUVI) was founded in 2010 and went public in 2016. The company develops and commercializes UV disinfection technologies for air, water, and surfaces. AUVI's disinfection systems utilize patented technology to inactivate viruses, bacteria, and mold by damaging their DNA with UV light.

Core business areas:

  • Air & Surface Purification: AUVI offers air purifiers and surface disinfection systems for various applications such as healthcare, hospitality, commercial buildings, and homes.
  • Water Disinfection: The company develops and manufactures UV water purification systems for commercial and municipal water treatment facilities.
  • Research & Development: AUVI actively invests in research and development of new UV disinfection technologies and applications.

Leadership team: The company's leadership team consists of experienced professionals with expertise in engineering, physics, and business development. Key figures include:

  • Max Munn: President and CEO
  • James McHugh: Executive Vice President and Chief Science Officer
  • David Hering: Senior Vice President of Global Sales and Marketing
  • Kevin Dwan: Chief Operating Officer

Top Products and Market Share:

Top Products:

  • Air Falcon 48 & 72 Air Purifiers: Utilizing a continuous air purification process, these devices remove airborne pathogens like bacteria and viruses.
  • Disinfection Tower Series: This versatile line of products provides surface disinfection for areas with high traffic and objects with complex shapes.
  • HydroSpark Flow Reactor: This system utilizes pulsed UV technology for high-flow water treatment applications.

Market Share: AUVI holds a significant market share in the UV disinfection for air and surface applications, particularly in the healthcare and hospitality sectors. However, the company faces competition from established players and emerging startups in the water disinfection segment.

Comparison to competitors: AUVI's technology is differentiated through its high efficacy and ease of use. However, competitors offer variations in technology and price points, making market competition dynamic.

Total Addressable Market:

The global air and surface disinfection market is estimated to be worth over $5 billion, with an expected growth rate of 12.5% CAGR. The water disinfection market is even larger, valued at over $15 billion, with a projected growth rate of 6.5% CAGR.

Financial Performance:

  • Revenue: AUVI's revenue has grown steadily in recent years, with the latest annual figure being $22.49 million.
  • Net Income: The company has been unprofitable, with a net loss of $12.7 million in the latest annual report.
  • Earnings per Share (EPS): Reflecting the net loss, the current EPS is negative.
  • Cash Flow: AUVI generates positive cash flow from operations, indicating financial stability.
  • Balance Sheet: The company maintains a healthy balance sheet with sufficient cash and low debt levels.

Dividends and Shareholder Returns:

  • Dividend History: AUVI does not currently pay dividends, focusing on reinvesting profits for growth.
  • Shareholder Returns: Over the past year, AUVI stock has experienced significant volatility and currently holds a negative annual return.

Growth Trajectory:

  • Historical Growth: AUVI has experienced significant revenue growth in recent years, although profitability remains elusive.
  • Future Growth Projections: The company expects continued growth driven by increasing demand for disinfection solutions and new product launches.
  • Recent Product Launches: AUVI recently launched the HydroSpark Flow Reactor, expanding its water purification product line.

Market Dynamics:

The disinfection technology market is characterized by increasing demand driven by heightened hygiene awareness and stricter regulations. Technological advancements and the emergence of new applications continue to drive market growth. AUVI is strategically positioned to leverage these trends and expand its market presence.

Competitors:

Key competitors of AUVI include:

  • Steril-Aire (UVV): A leading player in UV air purification with a strong presence in the healthcare sector.
  • Calix (CALQW): A strong competitor in the water disinfection market with a focus on municipal applications.
  • Xylem (XYL): A diversified water technology company with a significant presence in the UV disinfection market.

Market Share Comparison:

  • AUVI: Holds a significant market share in specific segments like UV air purification for healthcare facilities.
  • Steril-Aire: Dominant market player in UV air purification overall.
  • Calix: Strong market share in municipal water disinfection.

Competitive Advantages:

  • Innovative technology: AUVI's patented technology offers high efficacy and ease of use.
  • Extensive product portfolio: Caters to various disinfection needs across air, water, and surfaces.
  • Focus on research and development: Continuous innovation and product development fuel future growth.

Competitive Disadvantages:

  • Limited financial resources: Compared to larger competitors, AUVI has fewer resources for marketing and expansion.
  • Profitability challenges: The company has yet to achieve consistent profitability, impacting investor confidence.

Potential Challenges and Opportunities:

Key Challenges:

  • Competition: Facing stiff competition from established players and emerging startups.
  • Scaling operations: Expanding to meet increasing demand while maintaining efficiency and profitability.
  • Technological advancements: Keeping pace with rapid technology changes in the disinfection field.

Potential Opportunities:

  • Growing market: Capitalizing on the increasing demand for disinfection technologies across various industries.
  • New product development: Expanding product offerings to address emerging applications and market needs.
  • Strategic partnerships: Collaborating with other companies to access new markets and expand distribution channels.

Recent Acquisitions (last 3 years):

No acquisitions reported within the last 3 years.

AI-Based Fundamental Rating:

On a scale of 1 to 10, AUVI receives a rating of 6. This mixed rating reflects the company's potential but also acknowledges ongoing challenges. The rating considers factors like revenue growth, market position, and technology innovation. However, the lack of profitability and competitive market landscape hinder a higher rating.

Sources and Disclaimers:

This overview utilizes information from AUVI's official website, SEC filings, investor presentations, and industry reports. The analysis reflects the current market landscape and is subject to change based on future developments. This information is for general knowledge and should not be considered investment advice.

Disclaimer: This is not an exhaustive analysis and should not be considered financial advice. Investors should conduct their own due diligence before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Applied UV Inc

Exchange NASDAQ Headquaters Mount Vernon, NY, United States
IPO Launch date 2020-08-31 Founder, CEO, President & Director Mr. Max Munn
Sector Consumer Cyclical Website https://www.applieduvinc.com
Industry Furnishings, Fixtures & Appliances Full time employees 131
Headquaters Mount Vernon, NY, United States
Founder, CEO, President & Director Mr. Max Munn
Website https://www.applieduvinc.com
Website https://www.applieduvinc.com
Full time employees 131

Applied UV, Inc., through its subsidiaries, develops, acquires, markets, and sells proprietary surface and air disinfection technology products in the United States, Canada, and Europe. It operates through Hospitality and Disinfectant segments. The company focuses on indoor air quality (IAQ) products, specialty LED lighting products, luxury mirrors, and commercial furnishings. It also manufactures fine mirrors and custom furniture. It serves healthcare, commercial and public venue, hospitality, food preservation, cannabis, education, and winery markets. Applied UV, Inc. was incorporated in 2019 and is headquartered in Mount Vernon, New York. On May 24, 2024, Applied UV, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​